Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PELI2 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
mRNA | SCN3A | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
mRNA | OR1C1 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
mRNA | OR52B6 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | LRRC24 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | TAS2R41 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | PRLHR | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | ZFHX2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | NSF | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | ZNF445 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |